154 related articles for article (PubMed ID: 2359032)
1. Sequential metabolism of salicylamide exclusively to gentisamide 5-glucuronide and not gentisamide sulfate conjugates in single-pass in situ perfused rat liver.
Xu X; Tang BK; Pang KS
J Pharmacol Exp Ther; 1990 Jun; 253(3):965-73. PubMed ID: 2359032
[TBL] [Abstract][Full Text] [Related]
2. Sequestered endoplasmic reticulum space for sequential metabolism of salicylamide. Coupling of hydroxylation and glucuronidation.
Tirona RG; Pang KS
Drug Metab Dispos; 1996 Aug; 24(8):821-33. PubMed ID: 8869815
[TBL] [Abstract][Full Text] [Related]
3. Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation.
Morris ME; Yuen V; Tang BK; Pang KS
J Pharmacol Exp Ther; 1988 May; 245(2):614-24. PubMed ID: 3367309
[TBL] [Abstract][Full Text] [Related]
4. Hepatic modeling of metabolite kinetics in sequential and parallel pathways: salicylamide and gentisamide metabolism in perfused rat liver.
Xu X; Pang KS
J Pharmacokinet Biopharm; 1989 Dec; 17(6):645-71. PubMed ID: 2635738
[TBL] [Abstract][Full Text] [Related]
5. First-pass metabolism of gentisamide: influence of intestinal metabolism on hepatic formation of conjugates. Studies in the once-through vascularly perfused rat intestine-liver preparation.
Hirayama H; Pang KS
Drug Metab Dispos; 1990; 18(5):580-7. PubMed ID: 1981705
[TBL] [Abstract][Full Text] [Related]
6. First-pass metabolism of salicylamide. Studies in the once-through vascularly perfused rat intestine-liver preparation.
Xu X; Hirayama H; Pang KS
Drug Metab Dispos; 1989; 17(5):556-63. PubMed ID: 2573500
[TBL] [Abstract][Full Text] [Related]
7. Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation.
Dawson JR; Weitering JG; Mulder GJ; Stillwell RN; Pang KS
J Pharmacol Exp Ther; 1985 Sep; 234(3):691-7. PubMed ID: 4032287
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of acetaminophen sulfation by 2,6-dichloro-4-nitrophenol in the perfused rat liver preparation. Lack of a compensatory increase of glucuronidation.
Fayz S; Cherry WF; Dawson JR; Mulder GJ; Pang KS
Drug Metab Dispos; 1984; 12(3):323-9. PubMed ID: 6145559
[TBL] [Abstract][Full Text] [Related]
9. Estimations of intestinal and liver first-pass metabolism in vivo. Studies on gentisamide conjugation in the rat.
Hirayama H; Morgado J; Gasinska I; Pang KS
Drug Metab Dispos; 1990; 18(5):588-94. PubMed ID: 1981706
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
Pang KS; Barker F; Schwab AJ; Goresky CA
J Pharmacol Exp Ther; 1994 Jul; 270(1):285-95. PubMed ID: 8035326
[TBL] [Abstract][Full Text] [Related]
11. Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver.
Chiba M; Schwab AJ; Goresky CA; Pang KS
Hepatology; 1998 Jan; 27(1):134-46. PubMed ID: 9425929
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
Waschek JA; Rubin GM; Tozer TN; Fielding RM; Couet WR; Effeney DJ; Pond SM
J Pharmacol Exp Ther; 1984 Jul; 230(1):89-93. PubMed ID: 6747835
[TBL] [Abstract][Full Text] [Related]
13. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation.
Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ; Stillwell RN
J Pharmacol Exp Ther; 1983 Mar; 224(3):647-53. PubMed ID: 6827487
[TBL] [Abstract][Full Text] [Related]
14. Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver.
Ratna S; Chiba M; Bandyopadhyay L; Pang KS
Hepatology; 1993 May; 17(5):838-53. PubMed ID: 8491453
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic method for the quantitation of salicylamide and its metabolites in biological fluids.
Xu X; Pang KS
J Chromatogr; 1987 Sep; 420(2):313-27. PubMed ID: 3693503
[TBL] [Abstract][Full Text] [Related]
16. Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.
Xu X; Selick P; Pang KS
J Pharmacokinet Biopharm; 1993 Feb; 21(1):43-74. PubMed ID: 8410683
[TBL] [Abstract][Full Text] [Related]
17. Cholestatic effect of harmol glucuronide in the rat. Prevention of harmol-induced cholestasis by increased formation of harmol sulfate.
Krijgsheld KR; Koster HJ; Scholtens E; Mulder GJ
J Pharmacol Exp Ther; 1982 Jun; 221(3):731-4. PubMed ID: 7086685
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of sulfation in the rat in vivo and in the perfused rat liver.
Mulder GJ
Fed Proc; 1986 Jul; 45(8):2229-34. PubMed ID: 3087784
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of harmol and transport of harmol conjugates in isolated rat hepatocytes.
Sundheimer DW; Brendel K
Drug Metab Dispos; 1983; 11(5):433-40. PubMed ID: 6138228
[TBL] [Abstract][Full Text] [Related]
20. Competing pathways in drug metabolism. II. An identical, anterior enzymic distribution for 2- and 5-sulfoconjugation and a posterior localization for 5-glucuronidation of gentisamide in the rat liver.
Morris ME; Yuen V; Pang KS
J Pharmacokinet Biopharm; 1988 Dec; 16(6):633-56. PubMed ID: 3251033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
